Kotsopoulos noted that BRCA carriers have a substantially increased lifetime risk of breast and ovarian cancer. Management of ...

A long-awaited study shows that screening for breast cancer with annual mammograms may not always be the best way to catch ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors ...

Lumpectomy has been the standard of care for low-risk, early-stage breast cancer, but now cryoablation — freezing cancer ...

WISDOM is an ongoing, pragmatic randomized breast cancer screening trial that included 28,372 women ages 40 to 74 years (mean ...

Overall, tucatinib add-on to first-line maintenance therapy for HER2-positive metastatic breast cancer delayed progression by ...

Male breast cancer is rare, but studies suggest it's more common — and more lethal — among veterans. Yet the Veterans Administration is making it harder for veterans with breast cancer to get care.

Cancer survivorship goes past treatment to focus on rebuilding strength, protecting function, and preventing complications ...

The use of hormone replacement therapy (HRT) does not have an adverse effect on breast cancer risk according to results from ...

Patients whose cancers were hormone receptor (HR) negative – that is, their tumor cells did not have proteins that bind to ...

Most premenopausal women with early breast cancer accepted GnRHa therapy during chemotherapy to preserve ovarian function, ...

A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an ...